home / stock / chaq / chaq quote
Last: | $8.41 |
---|---|
Change Percent: | -10.15% |
Open: | $9.35 |
Close: | $8.41 |
High: | $9.35 |
Low: | $8.06 |
Volume: | 241,663 |
Last Trade Date Time: | 09/02/2021 04:43:44 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8.41 | $9.35 | $8.41 | $9.35 | $8.06 | 241,663 | 09-02-2021 |
$9.36 | $10.02 | $9.36 | $10.02 | $8.78 | 105,225 | 09-01-2021 |
$9.62 | $10 | $9.62 | $10.1 | $9.32 | 61,270 | 08-31-2021 |
$10.15 | $9.82 | $10.15 | $10.5203 | $9.13 | 214,923 | 08-30-2021 |
$9.99 | $10 | $9.99 | $10.3 | $9.9 | 324,485 | 08-27-2021 |
$10.02 | $9.99 | $10.02 | $10.254 | $9.65 | 562,959 | 08-26-2021 |
$9.9543 | $9.97 | $9.9543 | $9.97 | $9.95 | 13,501 | 08-25-2021 |
$9.953 | $9.95 | $9.953 | $9.953 | $9.95 | 50,500 | 08-24-2021 |
$9.9563 | $9.95 | $9.9563 | $9.9749 | $9.95 | 22,214 | 08-23-2021 |
$9.95 | $9.95 | $9.95 | $9.955 | $9.95 | 38,758 | 08-20-2021 |
$9.95 | $9.95 | $9.95 | $9.9641 | $9.95 | 3,601 | 08-19-2021 |
$9.9686 | $9.99 | $9.9686 | $9.99 | $9.96 | 304 | 08-18-2021 |
$9.97 | $9.97 | $9.97 | $9.9799 | $9.97 | 4,392 | 08-17-2021 |
$10 | $10.0101 | $10 | $10.0101 | $9.97 | 2,749 | 08-16-2021 |
$10 | $9.99 | $10 | $10.06 | $9.98 | 12,002 | 08-13-2021 |
$10.0002 | $10.09 | $10.0002 | $10.09 | $10 | 33,408 | 08-12-2021 |
$10.02 | $9.9699 | $10.02 | $10.02 | $9.9699 | 4,497 | 08-11-2021 |
$9.97 | $9.96 | $9.97 | $10.05 | $9.95 | 9,272 | 08-10-2021 |
$10.05 | $10.0899 | $10.05 | $10.0899 | $10.005 | 7,432 | 08-05-2021 |
$10.0199 | $9.97 | $10.0199 | $10.0199 | $9.97 | 500 | 08-04-2021 |
News, Short Squeeze, Breakout and More Instantly...
Chardan Healthcare Acquisition 2 Corp. Company Name:
CHAQ Stock Symbol:
NYSE Market:
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc. PR Newswire NEW YORK , Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition com...
Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer - Dr. Killeen joins Renovacor from BioMarin where he led the discovery and development of AAV-based gene therapies for inherited cardiac diseases PR N...
Chardan Healthcare Acquisition 2 Corp. Announces Record Date for Stockholders Eligible to Vote on Merger PR Newswire PHILADELPHIA and NEW YORK , Aug. 3, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (the "Company") announced that the close ...